UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Application of New Cholesterol Guidelines to a Population-Based Sample

The New England journal of medicine, 2014-04, Vol.370 (15), p.1422-1431

2014

Volltextzugriff (PDF)

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding

Journal of lipid research, 2018-07, Vol.59 (7), p.1266-1275

2018

Volltextzugriff (PDF)

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9417

2022

Volltextzugriff (PDF)

Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women

Clinical chemistry (Baltimore, Md.), 2017-04, Vol.63 (4), p.870-879

2017

Volltextzugriff (PDF)

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB

Current opinion in lipidology, 2014-12, Vol.25 (6), p.461-467

2014

Volltextzugriff (PDF)

The Necessity for Clinical Reasoning in the Era of Evidence-Based Medicine

Mayo Clinic proceedings, 2013-10, Vol.88 (10), p.1108-1114

2013

Volltextzugriff (PDF)

ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease

Clinical chemistry (Baltimore, Md.), 2021-11, Vol.67 (11), p.1440-1442

Sniderman, Allan D

2021

Volltextzugriff (PDF)

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report

Arteriosclerosis, thrombosis, and vascular biology, 2016-12, Vol.36 (12), p.2421-2423

2016

Volltextzugriff (PDF)

The Severe Hypercholesterolemia Phenotype: Clinical Diagnosis, Management, and Emerging Therapies

Journal of the American College of Cardiology, 2014-05, Vol.63 (19), p.1935-1947

2014

Volltextzugriff (PDF)

Age as a modifiable risk factor for cardiovascular disease

The Lancet (British edition), 2008-05, Vol.371 (9623), p.1547-1549

2008

Volltextzugriff (PDF)

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

Clinical chemistry (Baltimore, Md.), 2019-02, Vol.65 (2), p.225-227

Sniderman, Allan D

2019

Volltextzugriff (PDF)

Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

The journal of clinical endocrinology and metabolism, 2003-04, Vol.88 (4), p.1594-1602

2003

Volltextzugriff (PDF)

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement

Journal of clinical lipidology, 2011-07, Vol.5 (4), p.264-272

2011

Volltextzugriff (PDF)

Influence of Hepatic Steatosis (Fatty Liver) on Severity and Composition of Dyslipidemia in Type 2 Diabetes

Diabetes care, 2006-08, Vol.29 (8), p.1845-1850

2006

Volltextzugriff (PDF)

Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte

Clinical science (1979), 2017-05, Vol.131 (9), p.791-797

2017

Volltextzugriff (PDF)

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

Annals of internal medicine, 2001-09, Vol.135 (6), p.447

2001

Volltextzugriff (PDF)

Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice

Journal of clinical lipidology, 2008-02, Vol.2 (1), p.36-42

Sniderman, Allan D., MD

2008

Volltextzugriff (PDF)

Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome

Current opinion in lipidology, 2007-12, Vol.18 (6), p.633-637

2007

Volltextzugriff (PDF)

Apolipoprotein B in cardiovascular risk assessment

Canadian Medical Association journal (CMAJ), 2023-08, Vol.195 (33), p.E1124-E1124

2023

Volltextzugriff (PDF)

L’apolipoprotéine B dans l’évaluation du risque cardiovasculaire

Canadian Medical Association journal (CMAJ), 2023-12, Vol.195 (47), p.E1644-E1645

2023

Volltextzugriff (PDF)

Apolipoprotein B: the Rosetta Stone of lipidology

Current opinion in endocrinology, diabetes, and obesity, 2021-04, Vol.28 (2), p.90-96

2021

Volltextzugriff (PDF)

An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB

Journal of clinical lipidology, 2016-09, Vol.10 (5), p.1248-1258

2016

Volltextzugriff (PDF)

Triglyceride-rich lipoprotein cholesterol and cardiovascular risk

Current opinion in lipidology, 2023-12, Vol.34 (6), p.259

2023

Volltextzugriff (PDF)

Using Age- and Sex-Specific Risk Thresholds to Guide Statin Therapy

Journal of the American College of Cardiology, 2015-04, Vol.65 (16), p.1633-1639

2015

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Aktive Filter

ThemaCardiac & Cardiovascular Systems

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(172)

Publikationsform

Artikel
(229)
Buchkapitel
(1)

Sprache

Englisch
(230)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Application of New Cholesterol Guidelines to a Population-Based Sample

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB

The Necessity for Clinical Reasoning in the Era of Evidence-Based Medicine

ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report

The Severe Hypercholesterolemia Phenotype: Clinical Diagnosis, Management, and Emerging Therapies

Age as a modifiable risk factor for cardiovascular disease

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement

Influence of Hepatic Steatosis (Fatty Liver) on Severity and Composition of Dyslipidemia in Type 2 Diabetes

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice

Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome

Apolipoprotein B in cardiovascular risk assessment

L’apolipoprotéine B dans l’évaluation du risque cardiovasculaire

Apolipoprotein B: the Rosetta Stone of lipidology

An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB

Triglyceride-rich lipoprotein cholesterol and cardiovascular risk

Using Age- and Sex-Specific Risk Thresholds to Guide Statin Therapy

Aktive Filter

Suchergebnisse filtern